Lewis Stuart
2021 - Cymabay Therapeutics
In 2021, Lewis Stuart earned a total compensation of $1.5M as Chief Commercial Officer at Cymabay Therapeutics.
Compensation breakdown
| Bonus | $20,000 |
|---|---|
| Non-Equity Incentive Plan | $100,348 |
| Option Awards | $1,153,152 |
| Salary | $257,692 |
| Other | $750 |
| Total | $1,531,942 |
Stuart received $1.2M in option awards, accounting for 75% of the total pay in 2021.
Stuart also received $20K in bonus, $100.3K in non-equity incentive plan, $257.7K in salary and $750 in other compensation.
Rankings
In 2021, Lewis Stuart's compensation ranked 7,162nd out of 12,415 executives tracked by ExecPay. In other words, Stuart earned more than 42.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,162 out of 12,415 | 42nd |
Division Manufacturing | 3,135 out of 5,505 | 43rd |
Major group Chemicals And Allied Products | 1,385 out of 2,375 | 42nd |
Industry group Drugs | 1,233 out of 2,096 | 41st |
Industry Pharmaceutical Preparations | 903 out of 1,546 | 42nd |
Source: SEC filing on April 26, 2022.
Stuart's colleagues
We found four more compensation records of executives who worked with Lewis Stuart at Cymabay Therapeutics in 2021.